← Back to Clinical Trials
Recruiting NCT06529328

NCT06529328 Trunk Stabilization vs. Core Stability Exercises: Impact on Balance and Walking Ability in Cerebral Palsy.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06529328
Status Recruiting
Phase
Sponsor Riphah International University
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2024-06-01
Primary Completion 2024-12-20

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 7 Years
Study Type INTERVENTIONAL
Interventions
core stability

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2024-06-01 with a primary completion date of 2024-12-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Brain lesions cause cerebral palsy, a chronic condition that affects movement, posture, and balance. Its causes range in age from pregnancy to postpartum, and they can impact the neurological, musculoskeletal, and sensory systems. This causes problems with balance, movement, and posture. It is essential to intervene early for improved life quality. Maintaining a constant center of gravity within your support base is referred to as balance. Walking is putting one foot on the ground at all times and lifting and lowering each foot in turn. The stability of the trunk and core is necessary for muscle coordination and deliberate motions. A study compares the efficiency of trunk stabilization and core exercises to enhance balance and evaluates mobility changes, such as altered muscle strength, endurance, and gait, as a result of two treatment approaches.

Eligibility Criteria

Inclusion Criteria: * ● Gender: both girls and boys; * ● Age: 2-7 years. * ● Diagnosis: spastic CP. * ● According to the modified Ashworth scale, the affected lower extremity's degree of spasticity falls between grades 1 and 2. * PBS \> 32. Exclusion Criteria: * ● Got a timing injection with botulinum toxin. * ● Epilepsy \| Seizures. * ● Lower limb surgery performed throughout the research period. * Any deformity or orthopedic condition that affects balance. Deficits in vision and hearing with a MACS score higher than three will not be considered. * ● PBS rating less than 32.

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ Imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Saba Munir, MS*

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06529328 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 7 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06529328 currently recruiting?

Yes, NCT06529328 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06529328 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06529328 clinical trial?

NCT06529328 is sponsored by Riphah International University. The principal investigator is Saba Munir, MS* at Riphah International University. The trial plans to enroll 24 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology